StrokeHumansCytochrome P-450 CYP2C19StrokeSecondary PreventionPlatelet Aggregation Inhibitors
Why Genetics Can't Be Ignored in Secondary Stroke Prevention: The CYP2C19 Challenge in Asia.
Anushika Raheja, Deidre Anne De Silva, Kaavya Narasimhalu
Published: 202610.1161/STROKEAHA.125.053534
Abstract
Stroke is a leading cause of death and disability globally, with Asia disproportionately affected. A critical barrier to effective secondary prevention is the high prevalence of CYP2C19 loss-of-function alleles, present in almost 75% of South and Eas…
Preview only. Read the full abstract at the source